BIT Biotech Opportunities R-I Fonds
65,47
EUR
+1,79
EUR
+2,81
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| BridgeBio Pharma Inc | US10806X1028 | 9,01% |
| Blueprint Medicines Corp | US09627Y1091 | 5,77% |
| SpringWorks Therapeutics Inc Ordinary Shares | US85205L1070 | 5,25% |
| Scholar Rock Holding Corp | US80706P1030 | 5,13% |
| Merus NV | NL0011606264 | 4,83% |
| Immunocore Holdings PLC ADR | US45258D1054 | 4,41% |
| argenx SE ADR | US04016X1019 | 3,98% |
| Viridian Therapeutics Inc | US92790C1045 | 3,79% |
| BioNTech SE ADR | US09075V1026 | 3,68% |
| Day One Biopharmaceuticals Inc | US23954D1090 | 3,44% |
| Sonstige | 50,70% |